 |
Using Heparin Therapy to Reverse Protein-losing Enteropathy in a Patient with CDG-Ib CME DisclosuresRelease Date: February 19, 2008; Valid for credit through February 19, 2009 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
- Using Heparin Therapy to Reverse Protein-losing Enteropathy in a Patient with CDG-Ib
Ylian S. Liem, MD, MSc
Lars Bode, PhD
Hudson H. Freeze, PhD
Frank W.G. Leebeek, MD, PhD
Adrienne A.M. Zandbergen, MD
J.H. Paul Wilson, MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe the classification of congenital disorders of glycosylation (CDG) groups
- Identify clinical manifestations of protein-losing enteropathy (PLE)
- Describe the best first-line diagnostic test for PLE
- List treatment strategies for localized intestinal lymphangiectasia
- Describe the appropriate dose of heparin to use for CDG patients with PLE
Authors and Disclosures Ylian S. Liem, MD, MSc
Disclosure: Ylian S. Liem, MD, MSc, has disclosed no relevant financial relationships.
Lars Bode, PhD
Disclosure: Lars Bode, PhD, has disclosed no relevant financial relationships. Hudson H. Freeze, PhD
Disclosure: Hudson H. Freeze, PhD, has disclosed no relevant financial relationships. Frank W.G. Leebeek, MD, PhD
Disclosure: Frank W.G. Leebeek, MD, PhD, has disclosed no relevant financial
relationships. Adrienne A.M. Zandbergen, MD
Disclosure: Adrienne A.M. Zandbergen, MD, has disclosed no relevant financial relationships. J.H. Paul Wilson, MD
Disclosure: J.H. Paul Wilson, MD, has disclosed no relevant financial relationships. Désirée Lie, MD, MSEd
Disclosure:
Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
